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1. Introduction 
The interferons exert their action on the replica- 
tion of viruses by inhibition of the viral genome ex- 
pression. The target viral genome function inhibited 
was shown for two RNA viruses to be primarily the 
viral genome transcription (vesicular stomatitis virus 
[ 1, 21, reovirus [ 31). 
In the case of other viruses the viral genome trans- 
lation is primarily affected by interferon (e.g. arbo- 
virus [ 41, encephalomyocarditis virus [ 51, vaccmia 
virus [6]). 
Concerning the DNA-containing simian virus 
(SV40), it was found that in monkey cells both the 
viral transcription and viral translation were reduced 
by the same rate by human interferon [7] . These 
findings support the hypothesis that the SV40 genome 
transcription is primarily affected by interferon. 
However with polyinosinic:polytidylic acid as an 
interferon inducing agent we had found that the viral 
translation (formation of tumor antigen) is inhibited 
by 99% or higher, whereas the formation of early 
viral RNA was reduced only to 20% [8,9]. These 
findings support the hypothesis that translation rather 
than transcription of SV40 genome is inhibited by 
interferon. 
In order to get further information whether inter- 
feron inhibits SV40 genome expression mainly at the 
North-Holland fiblishing Company - Amsterdam 
level of transcription or translation SV40 cRNA was 
synthesized in vitro with E. coli RNA polymerase. For 
translation, this cRNA was injected into monkey 
kidney cells(TC7) by means of our microinjection 
technique [lo-121. 
2. Materials and methods 
2.1. Preparation of human interferon 
Human skin fibroblasts were stimulated with poly- 
inosmic:polycytidylic acid [ 131. The crude interferon 
preparations contained 2-4 X lo3 units ml-l when 
tested with vesicular stomatitis virus on human skin 
fibroblasts. In some experiments we used partially 
purified interferon preparation, from Newcastle 
disease virus-stimulated human leucocytes, which was 
a gift from the Behringwerke AG, Marburg. 
2.2. Cell culture and virus 
For all experiments TC7 cells, a subline of the CVl 
line of African green monkey kidney cells (kindly 
supplied by Care1 Mulder, Cold Spring Harbor Labora- 
tory), and SV40 strain 777 were used. 
2.3. Detection of SV40 tumor antigen (T-antigen) 
The detection of SV40 T-antigen by immunfluor- 
esence technique and preparation of anti SV40 T-anti- 
gen sera in monkeys is described elsewhere [8] . 
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Table 1 Table 2 
Effect of interferon on the translation of SV40 cRNA in- 
jected into TC7 cells 
SV40 T-antigen formation TC7 cell nuclei 
Experiment Percent of T-antigen 
positive nuclei 
Injection of SV40 cRNA 40.0* 
Interferon-pretreatment, 
injection of SV40 cRNA 0.1* 
Injection of SV40 DNA I 59.0* 
Interferon-pretreatment, 
injection of SV40 DNA I 0.2* 
Infection with SV40 50.0+* 
Interferon-pretreatment, 
infection with SV40 OS’* 
* Each measurement isbased on a count of 3 x lo2 in- 
jected cells. The cells were stained for T-antigen 24 hr 
after injection. 
Injection of Detection of T-antigen 
SV40 cRNA, DNase treated + 
SV40 cRNA in actinomycin D 
treated cells + 
SV40 cRNA, RNase treated - 
SV40 cRNA, alkaline treated - 
RNA from TC7 cells - 
Each measurement is based on a count of 3 x lo2 injected 
cells. The cells were stained for T-antigen 24 hr after injec- 
tion. 
** Precent of T-antigen positive cells of virus infected culture. 
The cells were stained for T-antigen 24 hr after the infec- 
tion. 
actinomycin D (a 30 min pretreatment before cRNA 
injection, during the injection procedure and through- 
out the following 10 hr of incubation time), the pro- 
portion of T-antigen positive cells was in the same 
range (12% 10 hr after infection) as in cells injected 
with cRNA but incubated in medium without actino- 
mycin D. 
2.4. Preparation of SV40 cRNA with E. coli RNA- 
polymerase 
The preparation is described elsewhere [ 141. 
2.5. Micro-injection of SV40 nucleic acids into TC7 
cells 
The procedure is described elsewhere [IO- 121. 
T-antigen formation was not inhibited when the 
cRNA was treated with pancreatic DNase (Worthing- 
ton Biochemical, 50 pg/ml, for 3 hr at 25°C 2 mM 
MgCl,) before injection. On the other hand, RNase 
(Worthington Biochemical, 50 /.&ml, for 90 min at 
25°C) and alkaline (pH 11.0) treatment destroyed the 
biological activity of the cRNA (table 2). 
3. Results 
The arrangement of T-antigen in the nuclei induced 
by in vitro cRNA was the same as in SV40 virus in- 
fected cells (fig. 1). 
3.1. Formation of SV40 T-antigen in TC7 cells injected 3.2. Inhibition of cRNA-induced T-antigen formation 
with SV40 cRhLA 
cRNA obtained by in vitro transcription of SV40 
DNA component I was injected into semi-confluent 
TC7 cells by means of micro-glass capillaries. The 
micro-injection was performed under a microscope at 
a 400-fold magnification. The recipient cells were 
grown on glass coverslides (divided into numbered 
squares of 1 mm2). About 5 X lo-I2 - lo-l1 ml of 
cRNA solution (0.1 mg/ml cRNA) were injected into 
each cell. 
in TC7 cells by human interferon 
To prove whether interferon can prevent SV40 
cRNA translation following micro-injection, TC7 cells 
were treated with human interferon (2000 units/ml) 
18 hr before cRNA injection. 24 hr after RNA injec- 
tion only 0.1% of the cells were positive for SV40 
T-antigen while 40% of the control cells (not inter- 
feron-treated but cRNA injected) exhibited T-antigen 
formation. 
As indicated in table 1 40% of the SV40 cRNA- 
injected cells showed SV40 T-antigen 24 hr after the 
injection. This SV40 cRNA-induced T-antigen forma- 
tion is not inhibited by actinomycin D (1 ccg/ml). In 
these experiments where TC7 cells were treated with 
The rate of reduction of T-antigen positive cells by 
interferon is in the same range when SV40 DNA 
(0.1 mg/ml) is injected into TC7 cells instead of virus 
cRNA (table 1). 
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Fig. 1. TC7 cell injected with SV40 cRNA and stained for 
T-antigen 24 hr after cRNA injection (1:400). 
4. Discussion 
The supercoiled forms of SV40 and polyoma virus 
are efficient templates for E. coli RNA polymerase. 
This enzyme transcribes preferentially the minus 
(early) strand in vitro. In vivo, the early virus messen- 
ger RNA is also transcribed from the minus strand 
while the late messenger RNA is preferentially trans- 
cribed from the plus (late) strand [14-181. 
Hence it is likely that the in vitro cRNA has messen- 
ger qualities for the early virus proteins. 
The experiments reported here prove that SV40 
T-antigen is virus- but not cell-coded. This was already 
demonstrated for polyoma virus T-antigen by injection 
of in vitro cRNA into mouse cells [ 191. 
From the actinomycin D resistance of the cRNA 
induced T-antigen synthesis it can be concluded that 
T-antigen formation as well as transport into the cell 
nuclei is independent from an additional expression of 
cellular genome functions. 
The inhibition of cRNA-induced T-antigen forma- 
tion by human interferon supports our hypothesis [8, 
91 that interferon inhibits primarily the translation 
of the SV40 genome. 
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